查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1632578

全球獸藥製劑市場：市場規模、佔有率及趨勢分析（按產品、動物類型、給藥途徑、劑型、地區和細分，2025-2030 年）

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

動物藥品市場的成長與趨勢：

根據 Grand View Research, Inc. 的一份新報告，到 2030 年全球獸藥市場規模預計將達到 24.5 億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 8.29%。推動市場成長的關鍵因素包括寵物數量的增加、龐大的獸醫醫療保健支出、飼主對特種藥物的認知不斷提高、品牌動物用藥品高成本、寵物人性化的趨勢以及對客製化獸藥複合藥物的需求不斷增加。

與全球其他幾個產業一樣，COVID-19 疫情在 2020 年對動物保健藥品市場產生了負面影響。 COVID-19 對動物保健系統最顯著的影響是供應鏈中斷、銷售下降、需求放緩以及法規和政策變化帶來的營運挑戰。許多地區進入全州封鎖狀態，並實施了對人員和貨物流動的限制，嚴重影響了製造商、獸醫藥房和獸醫護理服務提供者。例如，根據美國獸醫協會的數據，2020年4月，約有60%的獸醫診所因冠狀病毒疫情而取消或推遲了服務，而到2020年7月，這一數字已下降至約30%。因此，COVID-19 的影響正在阻礙市場成長。

動物用藥品配製填補了缺乏可用於獸醫護理的核准藥物和替代動物用藥品而留下的空白。當難以獲得 FDA 批准的針對特定疾病的藥物時，複方藥物可以成為治療多種動物疾病的更好選擇。例如，咀嚼片可能是特定劑型的商業性核准產品，並建議用於某些動物物種，但不適合用於貓和異國風寵物等動物。同樣，廣泛使用的商業藥物對某些動物來說有令人不愉快的味道，限制了給藥率。在這些情況下，特別是對於難以給藥的藥物，最好使用獸醫製劑。

疫情期間，寵物擁有量大幅增加，帶動獸醫保健基礎設施增加，推動獸醫組合藥物市場的發展。根據美國防止虐待動物協會（ASPCA）2021年5月發布的報告，自新冠疫情爆發以來，五分之一的家庭養了貓或狗。疫情期間收養引發了人們對寵物健康興趣的增加，預計將推動未來幾年獸藥市場的擴張。

同樣，隨著市場參與企業關注獸醫健康計劃和舉措，全球獸藥市場預計將擴大。例如，2021 年 6 月，Covetrus 收購了 VCP，這是一個管理獸醫健康計劃的平台，為大約 1,000 家診所提供服務，目前透過 VCP 支持的健康計劃使超過 350,000 隻寵物受益。 Covetrus 利用 VCP 提供的基礎設施和技術平台，為獸醫提供新的方式與寵物飼主建立更密切的關係，並推動更好的業務和臨床結果。

動物藥品市場：分析概述

  • 根據動物類型，寵物產業預計將在 2024 年佔據最大的收益佔有率。這是由於飼養寵物的人數不斷增加、在動物身上的支出不斷增加以及對寵物複合藥物的需求不斷增加。
  • 根據產品，中樞神經系統藥物部分在 2024 年佔據約 33% 的市場佔有率。中樞神經系統藥物是治療寵物行為改變、失明、癲癇和癲癇等神經系統疾病最常使用的藥物。荷爾蒙和替代藥物是一個快速成長的領域，成長速度超過 9.0%，因為它們更適合且更有效治療動物荷爾蒙失衡。
  • 在給藥途徑中，口服藥物是最受歡迎、最方便和最被接受的給藥途徑，因此口服藥物部分將在 2024 年佔據最大的市場佔有率，超過 53%。另一方面，依給藥途徑分類，外用製劑是成長最快的領域，預測期內成長率超過 9.0%。
  • 根據劑型，懸浮液部分將在 2024 年佔據最大的收入佔有率，約 49%，因為懸浮液是動物最常用的劑型。由於溶液相對於其他固態劑型具有多種優勢，預計未來幾年溶液部分將實現最高的複合年成長率，超過 8%。與固態形式相比，溶液通常吸收更快，並且對胃腸黏膜更溫和。此外，與懸浮液不同，溶液在儲存過程中不會發生相分離問題。因此，預計溶液配方在預測期內將變得更加流行。
  • 由於飼養寵物數量增加、獸醫醫療費用上漲以及獸醫製劑需求旺盛，預計到 2024 年北美將佔據地區最高市場佔有率，約 40%。由於寵物人性化的不斷提高、獸醫醫療保健支出的不斷增加以及低成本獸藥的普及，預計亞太地區的複合年成長率將達到約 10.0%，為最快的成長地區。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章動物藥品市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章動物藥品市場：按產品分類的業務分析

  • 按產品市場佔有率（2024 年和 2030 年）
  • 產品儀表板
  • 依產品分類的市場規模預測及趨勢分析（2018-2030）
  • 抗感染劑
  • 抗發炎劑
  • 荷爾蒙和替代品
  • 中樞神經系統 (CNS) 藥物
  • 其他產品

第 5 章動物藥品市場：按動物類型進行的業務分析

  • 各動物類型的市場佔有率（2024 年和 2030 年）
  • 動物物種儀表板
  • 按動物類型分類的市場規模預測及趨勢分析（2018-2030 年）
  • 寵物
  • 家畜

第6章動物藥品市場：依給藥途徑進行的業務分析

  • 按管理途徑分類的市場佔有率（2024 年和 2030 年）
  • 管理路線儀表板
  • 依管理途徑分類的市場規模預測及趨勢分析（2018-2030 年）
  • 口服藥物
  • 注射劑
  • 外用製劑
  • 其他路線

第 7 章動物藥品市場：按劑型分類的業務分析

  • 按劑型分類的市場佔有率（2024 年和 2030 年）
  • 按劑型分類的儀表板
  • 按劑型分類的市場規模預測及趨勢分析（2018-2030年）
  • 暫停
  • 解決方案
  • 膠囊

第 8 章動物藥品市場：區域估計和趨勢分析（按產品、動物類型、給藥途徑和劑型）

  • 按地區分類的市場佔有率分析（2024 年和 2030 年）
  • 區域市場儀表板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 市場參與企業概況
  • 公司市場地位分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • WEDGEWOOD PHARMACY
    • Vimian
    • Pharmaca
    • Akina Animal Health
    • Triangle Compounding
    • Davis Islands Pharmacy and Compounding Lab
    • Custom Med Compounding Pharmacy
    • Central Compounding Center South
    • Wellness Pharmacy of Cary
    • Miller's Pharmacy

第10章 重點

Product Code: GVR-4-68040-040-6

Animal Drug Compounding Market Growth & Trends:

The global animal drug compounding market size is anticipated to reach USD 2.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.29% from 2025 to 2030. The key factors driving the market growth include a rise in pet adoption, huge animal healthcare spending, increased pet owner awareness regarding specialty pharmaceuticals, the high cost of branded veterinary products, pet humanization trends, and an increase in the demand for custom-made, compounded animal medications.

The COVID-19 pandemic had a negative impact on the market for animal drug compounding in 2020, just like on several other global industries. The most significant effects of COVID-19 on the veterinary healthcare system are supply chain disruptions, a drop in sales, a slowdown in demand, and operational challenges brought on by shifting regulations and policies. Manufacturing firms, veterinary pharmacies, and animal care service providers were severely impacted as many areas entered state-wide lockdowns and imposed restrictions on the movement of people and goods. For instance, according to the American veterinary medical association, in April 2020, approximately 60% of veterinary practices were canceled or delayed due to the outbreak of coronavirus and in July 2020, the number of veterinary practices declined to about 30%. Thus, the impact of COVID-19 has hampered market growth.

Compounding veterinary drugs fills the gaps left by less readily available licensed drugs for veterinary treatment and other veterinary medication alternatives. Compounded medications are a better choice for treating a wide range of animal diseases when FDA-approved drugs are difficult to find for certain medical conditions. For instance, chewable tablets are commercially approved products in specific dosage forms and are suggested for use in certain animal species yet are unacceptable for use in animals such as cats or exotic pets. Similarly, widely available medications have an unpleasant taste for some animals limiting the administering rate. In this case, animal drug compounding is preferred, particularly for difficult-to-administer medications.

During the pandemic, pet adoption considerably increased, leading to an increased animal healthcare infrastructure and driving the market for compounded medications for animals. According to a report published by the American Society for the Prevention of Cruelty to Animals (ASPCA) in May 2021, one in every five families had adopted a cat or dog since the COVID-19 pandemic began. The increased focus on pet health brought on by adoptions during the pandemic is expected to drive the expansion of the animal drug compounding market over the coming years.

Similarly, the global animal drug compounding market is expected to expand due to market players focusing on programs and initiatives concerning veterinary health. For instance, in June 2021, Covetrus acquired VCP, a platform for administering veterinary wellness plans that serves about 1,000 practices and presently benefits over 350,000 pets through wellness plans that are enabled by VCP. Covetrus will make use of the infrastructure and technology platform provided by VCP to offer new methods for vets to develop closer bonds with their pet owners and produce better results in terms of both business and healthcare.

Animal Drug Compounding Market Report Highlights:

  • Based on animal type, the companion animals segment accounted for the largest revenue share in 2024. This can be attributed to the increasing adoption of pet animals, the rise in animal expenditure, and the increasing demand for compounding medication for pet animals.
  • Based on products, the CNS agents segment dominated with a market share of around 33% in 2024, as CNS agents are the most frequently prescribed medication for treating neurological conditions such as changes in behavior, blindness, seizures, epilepsy, etc., in pets. Hormones & Substitutes is the fastest-growing segment with a rate of over 9.0% since it is better and more potent for hormonal imbalance treatment in animals.
  • Among routes of administration, the oral segment held the largest market share of more than 53 % in 2024, as oral formulations are the preferred, easy, and more acceptable route of drug administration. Whereas, topical is the fastest-growing segment among the routes of administration, with a growth rate of over 9.0% during the forecast period.
  • Based on dosage form, the suspensions segment accounted for the largest revenue share of about 49% in 2024, as suspensions were the most dispensed compounded dosage form for animals. The Solutions segment is estimated to register the highest CAGR of over 8% in the coming years owing to the several benefits of the solution compared to another solid dosage form. Solutions are usually more GI mucosa-friendly than solid dosage forms as they are more quickly absorbed. In addition, unlike suspensions, phase separation during storing is not an issue with solutions. Thus, solutions are expected to gain popularity during the forecast period.
  • North America attributed the largest share of about 40% of the market by region in 2024, owing to an increase in pet ownership together with rising animal health expenditure and high demand for animal drug compounding. While Asia pacific is expected to grow at the fastest CAGR of about 10.0% due to an increase in pet humanization, growing animal healthcare expenditure, and the availability of low-cost animal compounding medications.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Type
    • 1.2.3. Route of Administration
    • 1.2.4. Dosage Form
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Animal Drug Compounding Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Animal Drug Compounding Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Anti-infective Agents
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Anti-inflammatory Agents
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Hormones & Substitutes
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. CNS Agents
    • 4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Other Products
    • 4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Animal Drug Compounding Market: Animal Type Business Analysis

  • 5.1. Animal Type Market Share, 2024 & 2030
  • 5.2. Animal Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
  • 5.4. Companion Animal
    • 5.4.1. Dogs
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Cats
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Horses
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Livestock Animal
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Animal Drug Compounding Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Oral
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Injectable
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Topical
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Other Routes
    • 6.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Animal Drug Compounding Market: Dosage Form Business Analysis

  • 7.1. Dosage Form Market Share, 2024 & 2030
  • 7.2. Dosage Form Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
  • 7.4. Suspensions
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Solutions
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Capsules
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Animal Drug Compounding Market: Regional Estimates & Trend Analysis by Product, Animal Type, Route of Administration, and Dosage Form

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Mexico animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Norway animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Denmark animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. South Korea animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Australia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Argentina animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Saudi Arabia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. UAE animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Kuwait animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. WEDGEWOOD PHARMACY
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Vimian
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Pharmaca
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Akina Animal Health
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Triangle Compounding
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Davis Islands Pharmacy and Compounding Lab
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Custom Med Compounding Pharmacy
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Central Compounding Center South
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Wellness Pharmacy of Cary
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Miller's Pharmacy
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives

Chapter 10. Key Takeaways

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 4 Global Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 7 Global Animal Drug Compounding Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 10 North America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 North America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 13 U.S. Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 U.S. Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 17 Canada Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 21 Mexico Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Mexico Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 25 Europe Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 Europe Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 30 Germany Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 34 UK Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 35 UK Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 UK Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 UK Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 38 France Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 39 France Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 France Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 France Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 42 Italy Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Italy Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 46 Spain Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 50 Denmark Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Denmark Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 54 Sweden Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 55 Sweden Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Sweden Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 58 Norway Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 59 Norway Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Norway Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Norway Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 67 China Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 68 China Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 China Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 China Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 71 Japan Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 72 Japan Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Japan Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 75 India Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 76 India Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 India Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 India Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 79 South Korea Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 South Korea Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Korea Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 83 Australia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 84 Australia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 85 Australia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Australia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 87 Latin America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 90 Latin America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Latin America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 92 Brazil Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Brazil Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 Brazil Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 96 Argentina Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 98 Argentina Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Argentina Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 100 Middle East & Africa Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
  • Table 101 Middle East & Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 102 Middle East & Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 105 South Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 South Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 South Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 113 UAE Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 115 UAE Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 116 UAE Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Animal Drug Compounding Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Animal Drug Compounding Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Animal Drug Compounding Market, for Anti-infective Agents, 2018 - 2030 (USD Million)
  • Fig. 16 Global Animal Drug Compounding Market, for Anti-inflammatory Agents, 2018 - 2030 (USD Million)
  • Fig. 17 Global Animal Drug Compounding Market, for Hormones & Substitutes, 2018 - 2030 (USD Million)
  • Fig. 18 Global Animal Drug Compounding Market, for CNS Agents, 2018 - 2030 (USD Million)
  • Fig. 19 Global Animal Drug Compounding Market, for Other Products, 2018 - 2030 (USD Million)
  • Fig. 20 Global Animal Drug Compounding Market, for Animal Type, 2018 - 2030 (USD Million)
  • Fig. 21 Global Animal Drug Compounding Market, for Companion Animal, 2018 - 2030 (USD Million)
  • Fig. 22 Global Animal Drug Compounding Market, for Dogs, 2018 - 2030 (USD Million)
  • Fig. 23 Global Animal Drug Compounding Market, for Cats, 2018 - 2030 (USD Million)
  • Fig. 24 Global Animal Drug Compounding Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Animal Drug Compounding Market, for Livestock Animal, 2018 - 2030 (USD Million)
  • Fig. 26 Global Animal Drug Compounding Market, for Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 27 Global Animal Drug Compounding Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 28 Global Animal Drug Compounding Market, for Injectable, 2018 - 2030 (USD Million)
  • Fig. 29 Global Animal Drug Compounding Market, for Topical, 2018 - 2030 (USD Million)
  • Fig. 30 Global Animal Drug Compounding Market, for Other Routes, 2018 - 2030 (USD Million)
  • Fig. 31 Global Animal Drug Compounding Market, for Dosage Form, 2018 - 2030 (USD Million)
  • Fig. 32 Global Animal Drug Compounding Market, for Suspensions, 2018 - 2030 (USD Million)
  • Fig. 33 Global Animal Drug Compounding Market, for Solutions, 2018 - 2030 (USD Million)
  • Fig. 34 Global Animal Drug Compounding Market, for Capsules, 2018 - 2030 (USD Million)
  • Fig. 35 Regional Outlook, 2024 & 2030
  • Fig. 36 North America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait Animal Drug Compounding Market, 2018 - 2030 (USD Million)
  • Fig. 63 Company categorization
  • Fig. 64 Company market position analysis
  • Fig. 65 Strategic framework